Form 4: VolitionRx Officer's RSU Tax Withholding

VolitionRx's Group Chief Marketing Officer, Ann-Louise Batchelor, reported a transaction for tax withholding related to restricted stock unit settlement.

Summary

• Ann-Louise Batchelor, Group Chief Marketing Officer of VolitionRx Ltd (VNRX), reported a transaction on September 28, 2025.
• The transaction involved the disposition of 5,604 shares of common stock.
• These shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations.
• The tax withholding was triggered by the settlement of 11,925 restricted stock units (RSUs).
• The deemed price for the withheld shares was $0.605 per share.
• No shares were sold by the reporting person or VolitionRx in this transaction.
• Following the transaction, Ann-Louise Batchelor directly owns 154,282 shares and indirectly owns 29,406 shares (by spouse).

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding on RSU vesting, which is neutral in sentiment and does not indicate positive or negative company performance.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which does not typically reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-sale transaction for tax purposes related to executive compensation.

Key Dates

Keywords

VNRX, VolitionRx, Form 4, Insider Transaction, RSU, Stock, Tax Withholding, Executive Compensation